Evidence map›Paper›PMID 41286848›Full record

Trial reportBMC medicine2025

Economic evaluation of a multi-component obesity prevention intervention in Chinese primary schools.

Shiyu Yan, Shuang Zhou, Xiru Guo, Jinlang Lyu, Hui Wang, Hai Fang, Hai-Jun Wang

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03665857 (A School-based Multicomponent Intervention Study for Preventing Excessive Weight Gain Among Primary School Students), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03665857 nacompletednot on this map

A School-based Multicomponent Intervention Study for Preventing Excessive Weight Gain Among Primary School Students

TypeinterventionalSponsorPeking UniversityRan2018 to 2021Enrolled1,392ConditionsPediatric ObesityArmsa multicomponent intervention
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shiyu YanDepartment of Maternal and Child Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center-Weifang Joint Research Center for Maternal and Child Health, Peking University, Beijing, China.
Shuang ZhouDepartment of Maternal and Child Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center-Weifang Joint Research Center for Maternal and Child Health, Peking University, Beijing, China.
Xiru GuoDepartment of Maternal and Child Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center-Weifang Joint Research Center for Maternal and Child Health, Peking University, Beijing, China.
Jinlang LyuDepartment of Maternal and Child Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center-Weifang Joint Research Center for Maternal and Child Health, Peking University, Beijing, China.
Hui WangDepartment of Maternal and Child Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center-Weifang Joint Research Center for Maternal and Child Health, Peking University, Beijing, China.
Hai FangChina Center for Health Development Studies, National Health Commission Key Laboratory of Reproductive Health, School of Public Health, Peking University, Beijing, China. hfang@hsc.pku.edu.cn.
Hai-Jun WangDepartment of Maternal and Child Health, School of Public Health, National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center-Weifang Joint Research Center for Maternal and Child Health, Peking University, Beijing, China. whjun@pku.edu.cn.

Funding

National Key Research and Development Program of China 2016YFC1300204National Natural Science Foundation of China 81973053
6 · The paper itself

Abstract

backgroundHealth economic evaluations of childhood obesity interventions are critical for determining the economic feasibility, sustainability, and scalability, thereby informing their policy relevance. This study conducted a comprehensive economic evaluation of a multi-component, App-assisted obesity prevention intervention-compared with usual care-to assess its value for widespread implementation.

methodsThe Diet, Exercise, and Cardiovascular Health-Children (DECIDE-Children) intervention was a cluster randomized clinical trial involving 24 schools across three socioeconomically distinct regions in China, targeting children aged 8 to 10 years. Schools were randomly assigned (1:1) to either the intervention group or the control group (usual health education). The intervention included school, family, and student components supported by a mobile application for health education, behavior monitoring, weight management, and feedback. A societal perspective was adopted for the economic evaluation. Total costs included direct financial expenditures (e.g., materials, equipment) and labor costs. Incremental cost-effectiveness ratios (ICERs) were calculated for primary obesity-related outcome measure. Using an obesity progression model, we estimated the number of adult obesity cases prevented up to age 65, quality-adjusted life years (QALYs) gained, incremental cost-utility ratio (ICUR), cost-benefit ratio (CBR), and net benefits.

resultsThe total cost of implementing the 1-year intervention was 13,769.74 USD, averaging 19.53 USD per student in the intervention group. Compared with usual care, the ICERs were as follows: 42.46 USD (95% CI 29.15 to 78.12) per 1-unit reduction in BMI; 11.49 USD (95% CI 7.81 to 21.70) per 0.1-unit reduction in BMI Z-score; 18.60 USD (95% CI 10.67 to 69.75) per 1% reduction in body fat percentage; 11.98 USD (95% CI 6.93 to 45.42) per 1-cm reduction in waist circumference. The ICUR was 4644.42 USD per QALY gained, and the CBR was 0.84. National implementation was projected to yield 419,040 QALYs gained and USD 1.86 billion in net benefits. Sensitivity analyses supported the robustness of findings.

conclusionsThe DECIDE-Children intervention is a cost-effective strategy for childhood obesity prevention, providing significant public health and economic benefits. Its integration of school, family, and digital components offers a scalable, sustainable model for addressing childhood obesity in China and other developing settings.

trial registrationClinicalTrials.gov Identifier NCT03665857.

Indexed as

Health PromotionPediatric ObesitySchool Health ServicesChildChinaCost-Benefit AnalysisEast Asian PeopleExerciseFemaleHealth EducationHumansMaleMobile ApplicationsQuality-Adjusted Life YearsSchoolsChildrenEconomic evaluationInterventionObesityPrevention

Identifiers

PMID41286848
PMCPMC12642123

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.